Febuxostat: 24 month predicted versus actual analysis
Page last updated: 15 March 2019
Drug utilisation sub-committee (DUSC)
September 2018
Abstract
Purpose
To compare the predicted and actual utilisation of febuxostat during the first 24 months of PBS listing (1 September 2015 to 1 August 2017).
Date of listing on the Pharmaceutical Benefits Scheme (PBS)
Febuxostat was listed on the PBS on 1 September 2015.
Data Source / methodology
Data for febuxostat was extracted from the Department of Human Services (DHS) prescription database from the date of listing on the PBS Schedule on 1 September 2015 to December 2017 (inclusive).
Key Findings
- The total number of patients supplied febuxostat was 2,421 in the first year and 4,881 in the second year of PBS listing. There were fewer patients than predicted in both years.
- The number of prescriptions supplied and Government expenditure were also lower than expected.
